| Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010 GH Mazurek, J Jereb, A Vernon, P LoBue, S Goldberg, K Castro, ... MMWR Recomm Rep 59 (RR-5), 1-25, 2010 | 1712* | 2010 |
| Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible … P Nahid, SE Dorman, N Alipanah, PM Barry, JL Brozek, A Cattamanchi, ... Clinical infectious diseases 63 (7), e147-e195, 2016 | 1697 | 2016 |
| Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States GH Mazurek, J Jereb, P LoBue, MF Iademarco, B Metchock, A Vernon MMWr recomm rep 54 (RR-15), 49-55, 2005 | 1029 | 2005 |
| Four-month rifapentine regimens with or without moxifloxacin for tuberculosis SE Dorman, P Nahid, EV Kurbatova, PPJ Phillips, K Bryant, KE Dooley, ... New England Journal of Medicine 384 (18), 1705-1718, 2021 | 450 | 2021 |
| Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis EL Nuermberger, T Yoshimatsu, S Tyagi, RJ O'Brien, AN Vernon, ... American journal of respiratory and critical care medicine 169 (3), 421-426, 2004 | 423 | 2004 |
| Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid A Vernon, W Burman, D Benator, A Khan, L Bozeman The Lancet 353 (9167), 1843-1847, 1999 | 422 | 1999 |
| Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis WJ Burman, S Goldberg, JL Johnson, G Muzanye, M Engle, AW Mosher, ... American journal of respiratory and critical care medicine 174 (3), 331-338, 2006 | 388 | 2006 |
| Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome BE Laughon, DA Druckman, A Vernon, TC Quinn, BF Polk, JF Modlin, ... Gastroenterology 94 (4), 984-993, 1988 | 354 | 1988 |
| Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis SE Dorman, JL Johnson, S Goldberg, G Muzanye, N Padayatchi, ... American journal of respiratory and critical care medicine 180 (3), 273-280, 2009 | 340 | 2009 |
| Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis D Menzies, A Benedetti, A Paydar, I Martin, S Royce, M Pai, A Vernon, ... PLoS medicine 6 (9), e1000146, 2009 | 289 | 2009 |
| Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis EL Nuermberger, T Yoshimatsu, S Tyagi, K Williams, I Rosenthal, ... American journal of respiratory and critical care medicine 170 (10), 1131-1134, 2004 | 280 | 2004 |
| Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis M Weiner, D Benator, W Burman, CA Peloquin, A Khan, A Vernon, ... Clinical infectious diseases 40 (10), 1481-1491, 2005 | 277 | 2005 |
| Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine M Weiner, W Burman, A Vernon, D Benator, CA Peloquin, A Khan, S Weis, ... American journal of respiratory and critical care medicine 167 (10), 1341-1347, 2003 | 275 | 2003 |
| the infectious diseases society. American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis HM Blumberg, WJ Burman, RE Chaisson, CL Daley, SC Etkind, ... Am J Respir Crit Care Med 167 (4), 603-62, 2003 | 274 | 2003 |
| Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model IM Rosenthal, M Zhang, KN Williams, CA Peloquin, S Tyagi, AA Vernon, ... PLoS medicine 4 (12), e344, 2007 | 262 | 2007 |
| Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis D Menzies, A Benedetti, A Paydar, S Royce, M Pai, W Burman, A Vernon, ... PLoS medicine 6 (9), e1000150, 2009 | 255 | 2009 |
| Lack of weight gain and relapse risk in a large tuberculosis treatment trial A Khan, TR Sterling, R Reves, A Vernon, CR Horsburgh, ... American journal of respiratory and critical care medicine 174 (3), 344-348, 2006 | 248 | 2006 |
| Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults JL Johnson, A Okwera, DL Hom, H Mayanja, CM Kityo, P Nsubuga, ... Aids 15 (16), 2137-2147, 2001 | 231 | 2001 |
| Sudden death among Southeast Asian refugees: an unexplained nocturnal phenomenon RC Baron, SB Thacker, L Gorelkin, AA Vernon, WR Taylor, K Choi Jama 250 (21), 2947-2951, 1983 | 216 | 1983 |
| Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis W Burman, D Benator, A Vernon, A Khan, B Jones, C Silva, C Lahart, ... American journal of respiratory and critical care medicine 173 (3), 350-356, 2006 | 211 | 2006 |
